| Oct 23 |
Evotec gains following $50M payment from Bristol for molecular glue degraders
|
| Oct 22 |
Bristol Myers (BMY) Upgraded to Buy: Here's What You Should Know
|
| Oct 22 |
BMY or VRTX: Which Is the Better Value Stock Right Now?
|
| Oct 18 |
Bristol-Myers Squibb (BMY): Growth Potential Amid Strategic Acquisitions and Revenue Increase
|
| Oct 17 |
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
|
| Oct 17 |
Bristol-Myers Squibb Company (BMY): A Bull Case Theory
|
| Oct 17 |
Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last?
|
| Oct 15 |
Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment
|
| Oct 15 |
Jim Cramer on Bristol-Myers Squibb Company (BMY): ‘I Think It’s A Great Time To Consider Buying This One’
|
| Oct 14 |
The Zacks Analyst Blog Highlights Bristol-Myers Squibb, Arthur J. Gallagher, TC Energy and Bridger Aerospace
|
